Home/ Stocks/ IDYA

IDEAYA Biosciences, Inc. Common Stock

IDYA XNAS

$37.02 +0.78 (+2.15%) ▲ 15-min delayed

Open

$36.50

High

$37.03

Low

$36.27

Volume

602.3K

Market Cap

$3.49B

About IDEAYA Biosciences, Inc. Common Stock

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 145 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q2 2026	$8.86M	$-112,452,000	$-1.22
Q1 2026	$6.56M	$-98,539,000	$-1.11
FY 2025	$218.71M	$-113,698,000	$-1.28
Q3 2025	$207.83M	$119.24M	$1.35

Earnings & Analyst Ratings

Next Earnings: Mon, Nov 2, 2026

Calendar →

Related Market News

No specific coverage for IDYA yet. Check out our latest market news or earnings calendar.

Get IDYA Alerts

Stay ahead with breaking news, price alerts, and expert analysis on IDEAYA Biosciences, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.